Should You Become a Biohacker with Metformin?
For years, studies hinted that metformin—a common diabetes drug—might help slow prostate cancer. But new results from the MAST trial show otherwise. Among men on Active Surveillance, metformin did not prevent disease progression compared to placebo, and side effects were more common. keep reading
